養殖用ワクチンの市場規模、シェア、成長分析、製品別、投与経路別、用途別、地域別 - 産業予測、2025～2032年

養殖用ワクチンの世界市場規模は、2023年に2億1,460万米ドルと評価され、2024年の2億3,091万米ドルから2032年には4億1,490万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.6％で成長する見通しです。

世界の養殖用ワクチン市場は、水産養殖種における細菌性およびウイルス性疾患の増加により、大きな成長が見込まれています。この増加は、ビブリオーシスとパスツレラ症に対抗するために2018年3月に発売されたギリシャのIcthiovac VR/PDのような革新的なワクチンの生産と採用の増加を促しています。新規養殖用ワクチン開発のための資金開拓が市場拡大をさらに後押ししています。DNAワクチンや組み換えワクチンへのシフトは、水産食品に対する消費者需要の高まりと相まって、この成長を促進すると予想されます。特に、Zoetis社のような企業は売上高が13%増加したと報告しており、業界が必需品に重点をシフトしていることを浮き彫りにしています。2016年から2019年にかけて水産養殖分野で219件以上の感染症事例が記録されており、効果的なワクチン接種ソリューションに対する需要は高まり続けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

養殖用ワクチン市場規模：製品別

• 市場概要
• 弱毒生ワクチン
• 不活化ワクチン
• サブユニットワクチン
• DNAワクチン
• 組み換えワクチン

養殖用ワクチン市場規模：投与経路別

• 市場概要
• 経口
• 注射
• 浸漬とスプレー

養殖用ワクチン市場規模：用途別

• 市場概要
• 細菌性
• ウィルス性
• 寄生虫
• その他

養殖用ワクチン市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Zoetis Inc.（USA）
• Merck Animal Health（USA）
• Elanco Animal Health（USA）
• Hipra（Spain）
• Ceva Sante Animale（France）
• Vaxxinova（Netherlands）
• AquaBounty Technologies（USA）
• Benchmark Holdings plc（UK）
• Pharmaq AS（Norway）
• Phibro Animal Health Corporation（USA）
• KBNP（South Korea）
• Nisseiken Co., Ltd.（Japan）
• Kyoto Biken Laboratories, Inc.（Japan）
• Cavac（China）
• VETERQUIMICA SA（Spain）
• CSL Limited（Australia）
• Emergent BioSolutions, Inc.（USA）
• Johnson & Johnson（USA）
• AstraZeneca plc（UK）
• Sanofi SA（France）

結論と推奨事項

Global Aquaculture Vaccine Market size was valued at USD 214.6 million in 2023 and is poised to grow from USD 230.91 million in 2024 to USD 414.9 million by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The global aquaculture vaccine market is poised for significant growth, driven by escalating bacterial and viral illnesses among aquaculture species. This rise is prompting increased production and adoption of innovative vaccines, such as Greece's Icthiovac VR/PD, launched in March 2018 to combat Vibriosis and Pasteurellosis. Enhanced funding for the development of novel aquaculture vaccines further supports market expansion. The shift towards DNA and recombinant vaccines, coupled with growing consumer demand for aquatic food products, is expected to fuel this growth. Notably, companies like Zoetis reported a 13% increase in sales, highlighting the industry's shift in focus toward essential goods. With over 219 infectious disease cases documented in the aquaculture sector from 2016 to 2019, the demand for effective vaccination solutions continues to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aquaculture Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aquaculture Vaccine Market Segmental Analysis

Global Aquaculture Vaccine Market is segmented by Product, Route of Administration, Application and region. Based on Product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines and Recombinant Vaccines. Based on Route of Administration, the market is segmented into Oral, Injected and Immersion & Spray. Based on Application, the market is segmented into Bacterial, Viral, Parasitic and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aquaculture Vaccine Market

The global aquaculture vaccine market is witnessing significant growth driven by a surge in disease outbreaks affecting seafood. Notably, incidents like the Pasteurella Skyensis outbreak in 2017, which led to the loss of approximately 125,000 salmon at farms in the Isle of Lewis, underscore the urgency for effective vaccination. Rising fish mortality rates, coupled with a growing demand for animal protein, are also propelling the need for aquaculture vaccines. Furthermore, government initiatives promoting vaccination programs and increased adoption of these vaccines in both developed and developing nations are stimulating market expansion. The global trade of aquaculture species is expected to provide additional momentum to the aquaculture vaccine market throughout the forecast period.

Restraints in the Global Aquaculture Vaccine Market

The global aquaculture vaccine market faces several constraints that may hinder its growth, primarily due to the challenges associated with handling and administering vaccines. The development of low-cost adjuvants and antigens that comply with environmental and regulatory standards can significantly affect market share, leading to reduced vaccine sales. Additionally, the requirement for highly skilled personnel to properly administer these vaccines complicates the process. Handling concerns also pose risks, including the potential for fungal infections during the vaccination process, further impeding the market's expansion and limiting the adoption of aquaculture vaccines in the industry.

Market Trends of the Global Aquaculture Vaccine Market

The Global Aquaculture Vaccine market is poised for significant growth, driven by technological advancements and an increasing incidence of aquaculture-related diseases. The rise in public-private partnerships focused on research and development fosters innovation, while enhanced diagnostic and therapeutic options in developing regions bolster product offerings. Additionally, rising per capita healthcare spending further propels market expansion. The emergence of strategic alliances and heightened internet connectivity also contribute to the sector's dynamism. Concerns regarding zoonotic diseases and their transmission from aquatic animals to humans are underscoring the urgency of advancing vaccine solutions, thereby solidifying the market's upward trajectory through 2023 and beyond.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Aquaculture Vaccine Market Size by Product & CAGR (2025-2032)

• Market Overview
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global Aquaculture Vaccine Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Injected
• Immersion & Spray

Global Aquaculture Vaccine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bacterial
• Viral
• Parasitic
• Others

Global Aquaculture Vaccine Market Size & CAGR (2025-2032)

• North America (Product, Route of Administration, Application)
  • US
  • Canada
• Europe (Product, Route of Administration, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route of Administration, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route of Administration, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route of Administration, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vaxxinova (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AquaBounty Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchmark Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaq AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KBNP (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nisseiken Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Biken Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cavac (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VETERQUIMICA SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations